D-glucose was recently suggested as a CEST-based biodegradable alternative to gadolinium-based contrast agents. Dynamic glucose-enhanced (DGE) MRI can retrieve information about glucose uptake, determined by tissue perfusion, transport, and metabolism. Motion artefacts in DGE-MRI can be mistaken for CEST effects, while motion correction may erroneously alter true DGE signal. A digital human head phantom based on a realistic glucose infusion protocol was developed to analyse motion artefacts and validate rigid-head retrospective motion correction. This phantom can be used for testing different correction approaches using various motion patterns and contrast responses to better understand these effects in vivo.
This abstract and the presentation materials are available to members only; a login is required.